
CAS 1018448-65-1
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Trastuzumab emtansine
CAS :Trastuzumab emtansine is a HER2-targeted ADC for advanced breast cancer, combining trastuzumab with DM1 cytotoxicity.Degré de pureté :98%Couleur et forme :LiquidTrastuzumab emtansine
CAS :<p>Antibody-drug conjugate (ADC) of HER2-targeted trastuzumab with cytotoxic microtubule-inhibitory agent DM1 (derivative of maytansine).</p>

